Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
2,751
Views
3
CrossRef citations to date
0
Altmetric
Nephrology
A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain
José Ramón González-Juanateya Servicio Cardiología, Hospital Clínico Universitario de Santiago de Compostela, Santiago De Compostela, Spain
https://orcid.org/0000-0001-9681-3388
Álvaro González-Francob Servicio Medicina Interna, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain
https://orcid.org/0000-0003-1220-6199
Patricia de Sequerac Servicio Nefrología, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
https://orcid.org/0000-0001-7705-9228
Marta Vallsd Market Access, Vifor Pharma Group., Barcelona, Spain
, Antonio Ramirez de Arellanoe Global HEOR, Vifor Pharma Group, Glattbrugg, Switzerland
, Elisenda Pomaresf Market Access, PharmaLex, Barcelona, Spain
& Diana Nievesf Market Access, PharmaLex, Barcelona, SpainCorrespondence[email protected]
show all
Pages 640-649
|
Received 04 Apr 2022, Accepted 03 May 2022, Published online: 19 May 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.